biotechScienceScientists’ Side Hustle? Using AI and Quantum Computing to Generate New PeptidesBy Isabella WardScienceA Startup Is Using Special Polymers to Better Help Nerves HealBy Isabella WardScience3 People Have Gotten Cancer-Detecting Implants in Their BrainsBy Emily MullinScienceThe Most Promising Ebola Vaccine Has Been Sitting on the Shelf for 15 YearsBy Isabella WardScienceAI-Designed Drugs by a DeepMind Spinoff Are Headed to Human TrialsBy Emily MullinScienceDesigner Baby Companies Are in TurmoilBy Marcelo Jauregui-VolpeScienceA Startup Says It Grew Human Sperm in a Lab—and Used It to Make EmbryosBy Emily MullinScienceA Billionaire-Backed Startup Wants to Grow 'Organ Sacks' to Replace Animal TestingBy Emily MullinScienceJapan Approves the World’s First Treatment Made With Reprogrammed Human CellsBy Ritsuko KawaiScienceThis Chinese Startup Wants to Build a New Brain-Computer Interface—No Implant RequiredBy Emily MullinScienceCrispr Pioneer Launches Startup to Make Tailored Gene-Editing TreatmentsBy Emily MullinScienceFormer Neuralink Exec Launches Organ Preservation EffortBy Emily MullinScienceParadromics Gets FDA Approval to Trial Its Brain Implant in PeopleBy Emily MullinScienceA Gene-Editing Therapy Cut Cholesterol Levels by HalfBy Emily MullinScienceA New Light-Based Cancer Treatment Kills Tumor Cells and Spares Healthy OnesBy Javier CarbajalScienceA New Startup Wants to Edit Human EmbryosBy Emily MullinJona’s Mail-Order Kit Helps You Decode Your MicrobiomeBy Brent RoseScienceScientist Who Was Offline 'Living His Best Life' Stunned by Nobel Prize WinBy Louise MatsakisScienceThe Next Era of Gene Editing Will Be Disease AgnosticBy Emily MullinScienceCrispr Offers New Hope for Treating DiabetesBy Javier CarbajalScienceResearchers Create 3D-Printed Artificial Skin That Allows Blood CirculationBy Ritsuko KawaiScienceNeuralink’s Bid to Trademark ‘Telepathy’ and ‘Telekinesis’ Faces Legal IssuesBy Emily MullinScienceChina Is Building a Brain-Computer Interface IndustryBy Emily MullinScienceRFK Jr. Is Supporting mRNA Research—Just Not for VaccinesBy Emily MullinMore Stories
